JP2022513237A5 - - Google Patents
Info
- Publication number
- JP2022513237A5 JP2022513237A5 JP2021534321A JP2021534321A JP2022513237A5 JP 2022513237 A5 JP2022513237 A5 JP 2022513237A5 JP 2021534321 A JP2021534321 A JP 2021534321A JP 2021534321 A JP2021534321 A JP 2021534321A JP 2022513237 A5 JP2022513237 A5 JP 2022513237A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382921.7A EP3666260A1 (en) | 2018-12-13 | 2018-12-13 | Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof |
| EP18382921.7 | 2018-12-13 | ||
| PCT/EP2019/084591 WO2020120548A1 (en) | 2018-12-13 | 2019-12-11 | ETHINYL ESTRADIOL-β-CYCLODEXTRIN COMPLEX AND PROCESS FOR PREPARING THEREOF |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022513237A JP2022513237A (ja) | 2022-02-07 |
| JP2022513237A5 true JP2022513237A5 (https=) | 2022-12-19 |
| JPWO2020120548A5 JPWO2020120548A5 (https=) | 2022-12-19 |
| JP7499252B2 JP7499252B2 (ja) | 2024-06-13 |
Family
ID=65003157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534321A Active JP7499252B2 (ja) | 2018-12-13 | 2019-12-11 | エチニルエストラジオール－β－シクロデキストリン複合体およびその製造方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12318395B2 (https=) |
| EP (1) | EP3666260A1 (https=) |
| JP (1) | JP7499252B2 (https=) |
| ES (1) | ES2850278B2 (https=) |
| WO (1) | WO2020120548A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3666260A1 (en) | 2018-12-13 | 2020-06-17 | Laboratorios Leon Farma SA | Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof |
| CN114225050B (zh) * | 2022-01-29 | 2022-12-13 | 国家卫生健康委科学技术研究所 | 炔雌醇环糊精复合物的制备及应用 |
| CN116617157B (zh) * | 2023-05-25 | 2025-02-18 | 国家卫生健康委科学技术研究所 | 一种制备pH响应性炔雌醇复合水凝胶的方法 |
| CN117257739A (zh) * | 2023-10-31 | 2023-12-22 | 武汉九珑人福药业有限责任公司 | 一种含有替勃龙的颗粒、固体制剂、片剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| DE4426709A1 (de) | 1994-07-20 | 1996-01-25 | Schering Ag | Steroidale Sexualhormone enthaltende feste Arzneiformen |
| IT1304190B1 (it) * | 1998-12-18 | 2001-03-08 | Euphar Group Srl | Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche |
| CH693905A5 (de) | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
| EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
| AU2013330219B2 (en) * | 2012-10-10 | 2018-02-08 | The University Of Queensland | Encapsulation of gases within cyclodextrins |
| EP2781214A1 (en) | 2013-03-22 | 2014-09-24 | Chemo Research, S.L. | Formulation of amorphous calcium L-5-methyltetrahydrofolate (L-5-MTHF-Ca) |
| US10471156B2 (en) * | 2014-12-19 | 2019-11-12 | Synthon B.V. | Pharmaceutical composition comprising amorphous lenalidomide |
| EP3666260A1 (en) | 2018-12-13 | 2020-06-17 | Laboratorios Leon Farma SA | Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof |
-
2018
- 2018-12-13 EP EP18382921.7A patent/EP3666260A1/en not_active Withdrawn
-
2019
- 2019-12-11 JP JP2021534321A patent/JP7499252B2/ja active Active
- 2019-12-11 ES ES202190031A patent/ES2850278B2/es active Active
- 2019-12-11 US US17/413,692 patent/US12318395B2/en active Active
- 2019-12-11 WO PCT/EP2019/084591 patent/WO2020120548A1/en not_active Ceased